Sampling for malaria molecular surveillance
The DOI matches its Crossref record.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Research is expanding on sampling strategies for malaria molecular surveillance, but much of the focus has been on P. falciparum [37] while focused efforts that consider the unique biology of P. vivax are greatly needed.”
From Building the toolkit to address malaria resurgence and radical cure of vivax malaria in Ethiopia: a meeting report (2026) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 78
- Neafsey, 2021, Advances and opportunities in malaria population genomics, Nat. Rev. Genet., 22, 502, 10.1038/s41576-021-00349-5 · DOI
- Tessema, 2019, Applying next-generation sequencing to track falciparum malaria in sub-Saharan Africa, Malar. J., 18, 268, 10.1186/s12936-019-2880-1 · DOI
- Volkman, 2012, Harnessing genomics and genome biology to understand malaria biology, Nat. Rev. Genet., 13, 315, 10.1038/nrg3187 · DOI
- Uwimana, 2020, Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda, Nat. Med., 26, 1602, 10.1038/s41591-020-1005-2 · DOI · Paper page
- da Silva, 2023, Targeted and whole-genome sequencing reveal a north-south divide in P. falciparum drug resistance markers and genetic structure in Mozambique, Commun. Biol., 6, 619, 10.1038/s42003-023-04997-7 · DOI
- Chang, 2019, Mapping imported malaria in Bangladesh using parasite genetic and human mobility data, Elife, 8, 10.7554/eLife.43481 · DOI · Paper page
- Sturrock, 2015, Tackling imported malaria: an elimination endgame, Am. J. Trop. Med. Hyg., 93, 139, 10.4269/ajtmh.14-0256 · DOI
- Taylor, 2017, Quantifying connectivity between local Plasmodium falciparum malaria parasite populations using identity by descent, PLoS Genet., 13, 10.1371/journal.pgen.1007065 · DOI · Paper page
- Archie, 2009, Infecting epidemiology with genetics: a new frontier in disease ecology, Trends Ecol. Evol., 24, 21, 10.1016/j.tree.2008.08.008 · DOI · Paper page
- Dalmat, 2019, Use cases for genetic epidemiology in malaria elimination, Malar. J., 18, 163, 10.1186/s12936-019-2784-0 · DOI
- Watson, 2021, Evaluating the performance of malaria genetics for inferring changes in transmission intensity using transmission modeling, Mol. Biol. Evol., 38, 274, 10.1093/molbev/msaa225 · DOI
- Neafsey, 2015, Genetic diversity and protective efficacy of the RTS,S/AS01 malaria vaccine, N. Engl. J. Med., 373, 2025, 10.1056/NEJMoa1505819 · DOI · Paper page
- Rovira-Vallbona, 2021, High proportion of genome-wide homology and increased pretreatment pvcrt levels in Plasmodium vivax late recurrences: a chloroquine therapeutic efficacy study, Antimicrob. Agents Chemother., 65, 10.1128/AAC.00095-21 · DOI
- Thawer, 2022, The use of routine health facility data for micro-stratification of malaria risk in mainland Tanzania, Malar. J., 21, 345, 10.1186/s12936-022-04364-7 · DOI
- Mitchell, 2022, Evaluating malaria prevalence and land cover across varying transmission intensity in Tanzania using a cross-sectional survey of school-aged children, Malar. J., 21, 80, 10.1186/s12936-022-04107-8 · DOI
- Mayor, 2019, Targeting pregnant women for malaria surveillance, Trends Parasitol., 35, 677, 10.1016/j.pt.2019.07.005 · DOI
- Kitojo, 2019, Estimating malaria burden among pregnant women using data from antenatal care centres in Tanzania: a population-based study, Lancet Glob. Health, 7, e1695, 10.1016/S2214-109X(19)30405-X · DOI · Paper page
- Stratton, 2021, Population research: convenience sampling strategies, Prehosp. Disaster Med., 36, 373, 10.1017/S1049023X21000649 · DOI · Paper page
- Ehrlich, 2020, Molecular surveillance of antimalarial partner drug resistance in sub-Saharan Africa: a spatial-temporal evidence mapping study, Lancet Microbe, 1, e209, 10.1016/S2666-5247(20)30094-X · DOI
- Nsanzabana, 2019, Strengthening surveillance systems for malaria elimination by integrating molecular and genomic data, Trop. Med. Infect. Dis., 4, 10.3390/tropicalmed4040139 · DOI
- Gupta, 2017, Molecular surveillance of pfhrp2 and pfhrp3 deletions in Plasmodium falciparum isolates from Mozambique, Malar. J., 16, 416, 10.1186/s12936-017-2061-z · DOI
- Gamboa, 2010, A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests, PLoS One, 5, 10.1371/journal.pone.0008091 · DOI · Paper page
- Agaba, 2019, Systematic review of the status of pfhrp2 and pfhrp3 gene deletion, approaches and methods used for its estimation and reporting in Plasmodium falciparum populations in Africa: review of published studies 2010-2019, Malar. J., 18, 355, 10.1186/s12936-019-2987-4 · DOI
- Rogier, 2022, Plasmodium falciparum pfhrp2 and pfhrp3 gene deletions from persons with symptomatic malaria infection in Ethiopia, Kenya, Madagascar, and Rwanda, Emerg. Infect. Dis., 28, 608, 10.3201/eid2803.211499 · DOI · Paper page
- Plowe, 2015, Vaccine-resistant malaria, N. Engl. J. Med., 373, 2082, 10.1056/NEJMe1511955 · doi:10.1056/nejme1511955
- Ikeda, 2018, Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014-2016, Emerg. Infect. Dis., 24, 718, 10.3201/eid2404.170141 · DOI · Paper page
- Straimer, 2022, High prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine, J. Infect. Dis., 225, 1411, 10.1093/infdis/jiab352 · DOI
- Rasmussen, 2022, Current and emerging strategies to combat antimalarial resistance, Expert Rev. Anti Infect. Ther., 20, 353, 10.1080/14787210.2021.1962291 · DOI
- Diez Benavente, 2020, A molecular barcode to inform the geographical origin and transmission dynamics of Plasmodium vivax malaria, PLoS Genet., 16, 10.1371/journal.pgen.1008576 · DOI · Paper page
- Obaldia, 2015, Clonal outbreak of Plasmodium falciparum infection in eastern Panama, J. Infect. Dis., 211, 1087, 10.1093/infdis/jiu575 · DOI
- de Oliveira, 2020, Population genomics reveals the expansion of highly inbred Plasmodium vivax lineages in the main malaria hotspot of Brazil, PLoS Negl. Trop. Dis., 14, 10.1371/journal.pntd.0008808 · DOI
- Sy, 2021, Genomic investigation of atypical malaria cases in Kanel, northern Senegal, Malar. J., 20, 103, 10.1186/s12936-021-03637-x · DOI
- Galatas, 2016, Malaria parasites in the asymptomatic: looking for the hay in the haystack, Trends Parasitol., 32, 296, 10.1016/j.pt.2015.11.015 · DOI
- Early, 2019, Detection of low-density Plasmodium falciparum infections using amplicon deep sequencing, Malar. J., 18, 219, 10.1186/s12936-019-2856-1 · DOI
- Pujol, 2023, Detecting temporal and spatial malaria patterns from first antenatal care visits, Res. Sq.
- Gonzalez, 2012, HIV and malaria interactions: where do we stand?, Expert Rev. Anti Infect. Ther., 10, 153, 10.1586/eri.11.167 · DOI
- Yobi, 2022, Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019, BMC Infect. Dis., 22, 145, 10.1186/s12879-022-07112-z · doi:10.1186/s12879-022-07112-z
- Verity, 2020, The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC, Nat. Commun., 11, 2107, 10.1038/s41467-020-15779-8 · DOI
- Guillot, 2022, Criteria for selecting sentinel unit locations in a surveillance system for vector-borne disease: a decision tool, Front. Public Health, 10, 10.3389/fpubh.2022.1003949 · DOI
- Racloz, 2006, Sentinel surveillance systems with special focus on vector-borne diseases, Anim. Health Res. Rev., 7, 71, 10.1017/S1466252307001120 · doi:10.1017/s1466252307001120
- Blickenstorfer, 2011, Using scenario tree modelling for targeted herd sampling to substantiate freedom from disease, BMC Vet. Res., 7, 49, 10.1186/1746-6148-7-49 · doi:10.1186/1746-6148-7-49
- Cameron, 2012, The consequences of risk-based surveillance: developing output-based standards for surveillance to demonstrate freedom from disease, Prev. Vet. Med., 105, 280, 10.1016/j.prevetmed.2012.01.009 · doi:10.1016/j.prevetmed.2012.01.009
- Adjah, 2018, Seasonal variations in Plasmodium falciparum genetic diversity and multiplicity of infection in asymptomatic children living in southern Ghana, BMC Infect. Dis., 18, 432, 10.1186/s12879-018-3350-z · DOI · Paper page
- Kobbe, 2006, Seasonal variation and high multiplicity of first Plasmodium falciparum infections in children from a holoendemic area in Ghana, West Africa, Tropical Med. Int. Health, 11, 613, 10.1111/j.1365-3156.2006.01618.x · DOI
- Mayor, 2008, Molecular markers of resistance to sulfadoxine-pyrimethamine during intermittent preventive treatment for malaria in Mozambican infants, J. Infect. Dis., 197, 1737, 10.1086/588144 · DOI
- Menendez, 2011, HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment, Clin. Infect. Dis., 52, 41, 10.1093/cid/ciq049 · DOI
- Brown, 2012, Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studies, Malar. J., 11, 333, 10.1186/1475-2875-11-333 · DOI
- Sy, 2022, Plasmodium falciparum genomic surveillance reveals spatial and temporal trends, association of genetic and physical distance, and household clustering, Sci. Rep., 12, 938, 10.1038/s41598-021-04572-2 · DOI
- Kabaghe, 2017, Adaptive geostatistical sampling enables efficient identification of malaria hotspots in repeated cross-sectional surveys in rural Malawi, PLoS One, 12, 10.1371/journal.pone.0172266 · DOI
- Graubard, 1996, Modelling the sampling design in the analysis of health surveys, Stat. Methods Med. Res., 5, 263, 10.1177/096228029600500304 · DOI
- Schaffner, 2018, hmmIBD: software to infer pairwise identity by descent between haploid genotypes, Malar. J., 17, 196, 10.1186/s12936-018-2349-7 · DOI · Paper page
- Gerlovina, 2022, Dcifer: an IBD-based method to calculate genetic distance between polyclonal infections, Genetics, 222, 10.1093/genetics/iyac126 · DOI · Paper page
- Daniels, 2015, Modeling malaria genomics reveals transmission decline and rebound in Senegal, Proc. Natl. Acad. Sci. U. S. A., 112, 7067, 10.1073/pnas.1505691112 · DOI · Paper page
- Lee, 2021, Modeling the levels, trends, and connectivity of malaria transmission using genomic data from a health facility in Thiès, Senegal, medRxiv
- Nkhoma, 2013, Population genetic correlates of declining transmission in a human pathogen, Mol. Ecol., 22, 273, 10.1111/mec.12099 · DOI · Paper page
- Searle, 2017, Distinct parasite populations infect individuals identified through passive and active case detection in a region of declining malaria transmission in southern Zambia, Malar. J., 16, 154, 10.1186/s12936-017-1810-3 · DOI
- Sisya, 2015, Subtle changes in Plasmodium falciparum infection complexity following enhanced intervention in Malawi, Acta Trop., 142, 108, 10.1016/j.actatropica.2014.11.008 · doi:10.1016/j.actatropica.2014.11.008
- Neafsey, 2017, Malaria genomics in the era of eradication, Cold Spring Harb. Perspect. Med., 7, 10.1101/cshperspect.a025544 · DOI
- Nelson, 2019, High-resolution micro-epidemiology of parasite spatial and temporal dynamics in a high malaria transmission setting in Kenya, Nat. Commun., 10, 5615, 10.1038/s41467-019-13578-4 · DOI
- Zhu, 2018, The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background, Nat. Commun., 9, 5158, 10.1038/s41467-018-07588-x · DOI
- Battle, 2016, Treatment-seeking rates in malaria endemic countries, Malar. J., 15, 20, 10.1186/s12936-015-1048-x · DOI · Paper page
- Blasco, 2017, Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic, Nat. Med., 23, 917, 10.1038/nm.4381 · DOI · Paper page
- Bushman, 2018, Within-host competition can delay evolution of drug resistance in malaria, PLoS Biol., 16, 10.1371/journal.pbio.2005712 · DOI · Paper page
- Griffith, 2020, Collider bias undermines our understanding of COVID-19 disease risk and severity, Nat. Commun., 11, 5749, 10.1038/s41467-020-19478-2 · DOI · Paper page
- Zejda, 2021, Seroprevalence of Anti-SARS-CoV-2 antibodies in a random sample of inhabitants of the Katowice Region, Poland, Int. J. Environ. Res. Public Health, 18, 3188, 10.3390/ijerph18063188 · DOI
- Lemmen, 2001, Implementing and evaluating a rotating surveillance system and infection control guidelines in 4 intensive care units, Am. J. Infect. Control, 29, 89, 10.1067/mic.2001.111415 · doi:10.1067/mic.2001.111415
- Murato, 2020, Evaluation of sampling methods for effective detection of infected pig farms during a disease outbreak, PLoS One, 15, 10.1371/journal.pone.0241177 · doi:10.1371/journal.pone.0241177
- Thompson, 1997, Spatial sampling, CIBA Found. Symp., 210, 161
- Salehi, 2021, Adaptive two-stage inverse sampling design to estimate density, abundance, and occupancy of rare and clustered populations, PLoS One, 16, 10.1371/journal.pone.0255256 · doi:10.1371/journal.pone.0255256
- Case, 2022, Spatial epidemiology and adaptive targeted sampling to manage the Chagas disease vector Triatoma dimidiata, PLoS Negl. Trop. Dis., 16, 10.1371/journal.pntd.0010436 · DOI
- Andrade-Pacheco, 2020, Finding hotspots: development of an adaptive spatial sampling approach, Sci. Rep., 10, 10939, 10.1038/s41598-020-67666-3 · DOI
- Wohl, 2023, Sample size calculations for pathogen variant surveillance in the presence of biological and systematic biases, Cell Rep. Med., 4
- Myatt, 2008, A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings, Antivir. Ther., 13, 37, 10.1177/135965350801302S10 · doi:10.1177/135965350801302s10
- Ginting, 2019, Rethinking antimicrobial resistance surveillance: a role for lot quality assurance sampling, Am. J. Epidemiol., 188, 734, 10.1093/aje/kwy276 · DOI
- Lanata, 1991, Lot quality assurance sampling techniques in health surveys in developing countries: advantages and current constraints, World Health Stat. Q., 44, 133
- Hedt, 2012, Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling, Epidemiology, 23, 293, 10.1097/EDE.0b013e3182459455 · doi:10.1097/ede.0b013e3182459455
- Smith-Aguasca, 2019, Mosquitoes as a feasible sentinel group for anti-malarial resistance surveillance by next generation sequencing of Plasmodium falciparum, Malar. J., 18, 351, 10.1186/s12936-019-2946-0 · DOI
- Nkemngo, 2022, Xeno-monitoring of molecular drivers of artemisinin and partner drug resistance in P. falciparum populations in malaria vectors across Cameroon, Gene, 821, 10.1016/j.gene.2022.146339 · DOI
Cited by
Degaga, T. S., Sime, H., Ruybal-Pesántez, S., Osborne, A., Mwaura, M., Bamboro, S. A., Mnjala, H., Mekonnen, G., Ermias, S., Fantahun, A., et al. (2026) · Malaria Journal · doi:10.1186/s12936-026-06050-4 · Cited by 1
Metadata
- Authors
- Mayor, A., Ishengoma, D. S., Proctor, J. L., & Verity, R.
- Venue
- Trends in Parasitology
- Publisher
- Elsevier BV
- Published
- 2023-11
- Volume
- 39
- Issue
- 11
- Pages
- 954-968
- ISSN
- 1471-4922
- Cited by
- 30
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- MRC
- Nigerian Institute of Medical Research
- Fundación Ramón Areces
- Foreign, Commonwealth and Development Office
- Departament d'Universitats, Recerca i Societat de la Informació (2021 SGR 01517)
- Agencia Española de Cooperación Internacional para el Desarrollo
- Imperial College London
- Generalitat de Catalunya
- Spain Ministry of Science and Innovation
- United States Agency for International Development
- Medical Research Council (MR/R015600/1)
- Bill & Melinda Gates Foundation (INV-031273, INV-019032, INV-002202)
- European Commission
- Agència de Gestió d'Ajuts Universitaris i de Recerca (CEX2018-000806-S, MCIN /AEI/10.13039/501100011033)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.